BMS-852927

InvivoChem Cat #:V3502CAS #:1256918-39-4 Purity >=98%

Description: BMS-852927 (also known as XL041) is a partial agonist of LXRbeta (liver X receptor beta). BMS-852927 had favorable profiles in animal models with a wide therapeutic index in cynomolgus monkeys and mice. In healthy subjects and hypercholesterolemic patients, reverse cholesterol transport pathways were induced similarly to that in animal models. However, increased plasma and hepatic TG, plasma LDL-C, apoB, apoE, and CETP and decreased circulating neutrophils were also evident. Furthermore, similar increases in LDL-C were observed in normocholesterolemic subjects and statin-treated patients. The primate model markedly underestimated human lipogenic responses and did not predict human neutrophil effects. These studies demonstrate both beneficial and adverse LXR agonist clinical responses and emphasize the importance of further translational research in this area.

References: Cell Metab. 2016 Aug 9; 24(2):223-33.

-20C for 3 years in powder form

Synonym: BMS-852927; BMS 852927; BMS852927; XL041; XL-041; XL 041.
Chemical Name: 2-(2-(2-(2, 6-dichlorophenyl)propan-2-yl)-1-(3, 3?-difluoro-4?-(hydroxymethyl)-5?-(methylsulfonyl)biphenyl-4-yl)-1H-imidazol-4-yl)propan-2-ol
InChi Key: HNAJDMYOTDNOBK-UHFFFAOYSA-N
InChi Code: InChI=1S/C29H28Cl2F2N2O4S/c1-28(2, 26-19(30)7-6-8-20(26)31)27-34-25(29(3, 4)37)14-35(27)23-10-9-16(11-22(23)33)17-12-21(32)18(15-36)24(13-17)40(5, 38)39/h6-14, 36-37H, 15H2, 1-5H3
SMILES Code: CC(O)(C1=CN(C2=CC=C(C3=CC(S(=O)(C)=O)=C(CO)C(F)=C3)C=C2F)C(C(C)(C4=C(Cl)C=CC=C4Cl)C)=N1)C